Skip to content
EDITORIAL EDITION
Federal SI Leaders/Civilian & Government-wide
FEDERAL SI LEADERS / ROLE BRIEFING

Jeremy Walsh.

CAIO

Food and Drug AdministrationCurrent-role profile
THE BIO / SOURCE-BASED SUMMARY

Background & responsibilities.

Jeremy Walsh is identified in FDA announcements as the agency’s CAIO. He helped coordinate the agency-wide rollout following its first assisted scientific-review pilot in 2025. Subsequent FDA releases describe his role in introducing agentic capabilities for staff workflows. The public record places his work at the intersection of scientific review, computing, and the practical adoption of advanced intelligence inside the regulator.

SI HOME ANALYSIS

Why the role matters.

FDA’s internal adoption should be distinguished from its regulation of products made by others. For a pursuit, identify whether the problem concerns agency operations, scientific tools, or an external regulatory obligation.

Official sources.

Sources reviewed October 19, 2026. A current-role profile is not a newly announced appointment. Check the agency source for later changes.